@Aggie_CIO@AggieCapitalist Competition, management trust / consistently disappointing, Olo decision not to take stock - but also the convert. Board should bring in new CEO and immediately address how they will handle convert.
$ECN.TO - Proxy confirms weak sauce process. Unclear why urgency to sell, cites 2023 (and "refreshed" 2024) market check to contact ZERO parties in 2025 post business and macro improvement, and no leverage against buyer group which was able to buy at low-end of prelim range
@KcrCap@KcrCap - what is argument for reasonably priced payments rev (particularly if "bundled" in broader offering) having a lower multiple? Is it greater risk of pricing compression or less moated?
US Fast food / chain sales have been resilient through economic downturn
Congrats to @CapitalVoss team for an incredible decade of returns and achieving their AUM goal! I know the team has put everything into this business for past decade. Great job all!
@jonrice80@AggieCapitalist
Who is $TBRD's corporate cousel? They seem to be confusing a take-over with a shareholder's right to nominate directors. I mean this in earnest - they need help and it's concerning management is making such amateurish public statements.
Great work @DrugChannels shedding light on the absolute bizzarro world that is the US Rx channel. Why can't PBM simply negotiate the best price for its customers vs. using smoke/mirror "discount cards" (obviously rhetorical...it's the $$$$).
https://t.co/H3v3bn1xjU
It seems like the right time to go long a stock is when twittersphere calls for near-term BK despite company having multiple quarters/year+ cash, no secured debt / no covenants, and no maturities for several years.